[go: up one dir, main page]

FI906008L - Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi - Google Patents

Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi Download PDF

Info

Publication number
FI906008L
FI906008L FI906008A FI906008A FI906008L FI 906008 L FI906008 L FI 906008L FI 906008 A FI906008 A FI 906008A FI 906008 A FI906008 A FI 906008A FI 906008 L FI906008 L FI 906008L
Authority
FI
Finland
Prior art keywords
stabilizing
heterocyclic compound
aqueous mixture
aqueous
heterocyclic
Prior art date
Application number
FI906008A
Other languages
English (en)
Swedish (sv)
Other versions
FI906008A0 (fi
FI97689C (fi
FI97689B (fi
Inventor
Den Oetelaar Petrus Johann Van
Maria Martina Francisc Mentink
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI906008A0 publication Critical patent/FI906008A0/fi
Publication of FI906008L publication Critical patent/FI906008L/fi
Application granted granted Critical
Publication of FI97689B publication Critical patent/FI97689B/fi
Publication of FI97689C publication Critical patent/FI97689C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI906008A 1989-12-06 1990-12-05 Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi FI97689C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89203092 1989-12-06
EP89203092 1989-12-06

Publications (4)

Publication Number Publication Date
FI906008A0 FI906008A0 (fi) 1990-12-05
FI906008L true FI906008L (fi) 1991-06-07
FI97689B FI97689B (fi) 1996-10-31
FI97689C FI97689C (fi) 1997-02-10

Family

ID=8202518

Family Applications (1)

Application Number Title Priority Date Filing Date
FI906008A FI97689C (fi) 1989-12-06 1990-12-05 Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi

Country Status (15)

Country Link
US (1) US5082864A (fi)
EP (1) EP0431663B1 (fi)
JP (1) JP2977912B2 (fi)
KR (1) KR0185377B1 (fi)
AT (1) ATE99943T1 (fi)
AU (1) AU628768B2 (fi)
CA (1) CA2030773C (fi)
DE (1) DE69005992T2 (fi)
DK (1) DK0431663T3 (fi)
ES (1) ES2062310T3 (fi)
FI (1) FI97689C (fi)
IE (1) IE63985B1 (fi)
NZ (1) NZ236332A (fi)
PT (1) PT96096B (fi)
ZA (1) ZA909568B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1591H (en) * 1992-10-09 1996-09-03 Fulcher; John Preparation of flavor-enhanced reduced calorie fried foods
IL107887A (en) * 1992-12-08 2003-07-06 Ambi Inc Stabilized lanthionine containing bacteriocin compositions
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
TW587938B (en) * 1997-03-27 2004-05-21 Akzo Nobel Nv Pharmaceutical composition for the treatment and/or prophylaxis of psychotic disorder
WO1999051237A1 (en) * 1998-04-02 1999-10-14 Akzo Nobel N.V. Oral liquid antidepressant solution
US6211171B1 (en) 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
US6495534B2 (en) 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
DE60224078T2 (de) * 2001-02-12 2008-12-04 N.V. Organon Verwendung von Mirtazapin zur Verbesserung der Behandlung von Menschen mit starken Depressionen, welche Träger des Gens für Apolipoprotein E4 sind.
US6399310B1 (en) 2001-02-12 2002-06-04 Akzo Nobel N.V. Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20030105082A1 (en) * 2001-12-03 2003-06-05 Murphy Greer Marechal Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20050215552A1 (en) * 2002-05-17 2005-09-29 Gadde Kishore M Method for treating obesity
MXPA05011557A (es) 2003-04-29 2006-03-09 Orexigen Therapeutics Inc Composiciones para afectar perdida de peso.
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
AU2005206139B2 (en) * 2004-01-13 2009-02-26 Duke University Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss
WO2006023702A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders with setiptiline
AU2005285040A1 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
EP1827450A4 (en) * 2004-11-17 2009-04-22 Cypress Bioscience Inc METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE
EP2292220A3 (en) * 2005-11-22 2012-01-04 Orexigen Therapeutics, Inc. Composition and methods for increasing insulin sensitivity
AU2007207606A1 (en) * 2006-01-17 2007-07-26 Regents Of The University Of Colorado Central administration of stable formulations of therapeutic agents for CNS conditions
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
CN101588795A (zh) 2006-11-09 2009-11-25 奥雷西根治疗公司 包含中间快速溶解层的分层药物制剂
AU2007319472B2 (en) 2006-11-09 2013-01-17 Nalpropion Pharmaceuticals Llc Methods Of Administering Weight Loss Medications
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
US20110144145A1 (en) * 2008-05-30 2011-06-16 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
CN102724878A (zh) * 2010-01-11 2012-10-10 奥雷西根治疗公司 在重度抑郁症患者中提供体重减轻疗法的方法
KR20220042241A (ko) 2012-06-06 2022-04-04 오렉시젠 세러퓨틱스 인크. 과체중 및 비만의 치료 방법
KR101652081B1 (ko) 2014-12-30 2016-08-30 김인호 전극보일러 급탕시스템
SI3261645T1 (sl) 2015-02-27 2021-08-31 Dechra Limited Stimulacija apetita, uravnavanje izgube mase in zdravljenje anoreksije pri psih in mačkah
KR20170001494A (ko) 2015-06-26 2017-01-04 김인호 전극보일러 전류제어시스템
CN108853042B (zh) * 2018-09-20 2021-03-26 北京哈三联科技有限责任公司 一种米氮平冻干口崩片及其制备方法和应用
GR1009883B (el) * 2019-06-07 2020-12-11 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν υδροχλωρικη νορτριπτυλινη

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082910A (en) * 1980-08-28 1982-03-17 Berk Pharmaceuticals Ltd Anti-depressant compositions
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
DE3247676A1 (de) * 1982-12-23 1984-06-28 A. Nattermann & Cie GmbH, 5000 Köln Galenische form fuer amitriptylinoxid und verfahren zur herstellung

Also Published As

Publication number Publication date
AU6779890A (en) 1991-06-13
CA2030773C (en) 2001-07-24
FI906008A0 (fi) 1990-12-05
JP2977912B2 (ja) 1999-11-15
AU628768B2 (en) 1992-09-17
IE63985B1 (en) 1995-06-28
FI97689C (fi) 1997-02-10
NZ236332A (en) 1992-07-28
PT96096A (pt) 1991-09-30
DE69005992T2 (de) 1994-05-05
KR0185377B1 (ko) 1999-05-01
DE69005992D1 (de) 1994-02-24
EP0431663A1 (en) 1991-06-12
US5082864A (en) 1992-01-21
ES2062310T3 (es) 1994-12-16
DK0431663T3 (da) 1994-03-07
EP0431663B1 (en) 1994-01-12
KR910011250A (ko) 1991-08-07
PT96096B (pt) 1998-02-27
JPH05262651A (ja) 1993-10-12
ZA909568B (en) 1991-09-25
ATE99943T1 (de) 1994-01-15
FI97689B (fi) 1996-10-31
CA2030773A1 (en) 1991-06-07
IE904226A1 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
FI906008L (fi) Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi
FI885917A7 (fi) Menetelmä heterosyklisten yhdisteiden valmistamiseksi
FI893433A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
KR860005811A (ko) 티아졸리딘디온 유도체의 제조방법
LV10452A (lv) (1H-Azol-1-ilmetil)-aizvietotu benzotriazolu atvasinajumu iegusanas metode
FI905941A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
ES552468A0 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
FI883064A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
BR8801098A (pt) Processo para a preparacao de um composto de imidazola
PT83876B (pt) Processo para a preparacao de derivados de butiramida n-substituidos
FI893100L (fi) Analogiamenetelmä asyylideoksiribonukleosidijohdannaisten valmistamiseksi
FI915741A7 (fi) Parannettu menetelmä substituoitujen isoflavonijohdannaisten valmistam iseksi
FI891700L (fi) Menetelmä beta-laktaamijohdannaisten valmistamiseksi
FI903104A0 (fi) Analogiamenetelmä asetyylikoliiniesteraasi-inhibiittoreina käyttökelpoisten yhdisteiden valmistamiseksi
FI871670L (fi) Menetelmä osseiini-hydroksiapatiittiyhdisteen valmistamiseksi
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI875102L (fi) Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
FI883479A7 (fi) Isotiatsolinonien stabilointimenetelmä
FI880716A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten aryylipiperatsinyylialkyleenifenyylisubstituoitujen heterosyklisten yhdisteiden valmistamiseksi
FI904393A7 (fi) Parannettu menetelmä amidoksiimijohdannaisten valmistamiseksi
ES499350A0 (es) Un metodo de preparacion de derivados de imidazolidinonas
ES552437A0 (es) Procedimiento para preparar un derivado fungicida de n-(2-cloro-4-trifluorometilfenil)-3-trifluorometilbencenosulfonamida
FI883538A7 (fi) Menetelmä uusien rikkiyhdisteiden valmistamiseksi
FI882894L (fi) Menetelmä 2-kinoksalinoliyhdisteen valmistamiseksi
DK30389A (da) Fremgangsmaade til fremstilling af carboxylsyrederivater

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: AKZO N.V.

PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON